The serotonin 6 receptor controls neuronal migration during corticogenesis via a ligand-independent Cdk5-dependent mechanism

od Jacobshagen, Moritz, Niquille, Mathieu, Chaumont-Dubel, Séverine, Marin, Philippe, Dayer, Alexandre
Wydane 2014

Novel and atypical pathways for serotonin signaling

od Bockaert, Joël, Bécamel, Carine, Chaumont-Dubel, Séverine, Claeysen, Sylvie, Vandermoere, Franck, Marin, Philippe
Wydane w Fac Rev (2021)

Physical interaction between neurofibromin and serotonin 5-HT(6) receptor promotes receptor constitutive activity

od Deraredj Nadim, Wissem, Chaumont-Dubel, Séverine, Madouri, Fahima, Cobret, Laetitia, De Tauzia, Marie-Ludivine, Zajdel, Pawel, Bénédetti, Hélène, Marin, Philippe, Morisset-Lopez, Séverine
Wydane w Proc Natl Acad Sci U S A (2016)

Early 5‐HT (6) receptor blockade prevents symptom onset in a model of adolescent cannabis abuse

od Berthoux, Coralie, Hamieh, Al Mahdy, Rogliardo, Angelina, Doucet, Emilie L, Coudert, Camille, Ango, Fabrice, Grychowska, Katarzyna, Chaumont‐Dubel, Séverine, Zajdel, Pawel, Maldonado, Rafael, Bockaert, Joël, Marin, Philippe, Bécamel, Carine
Wydane w EMBO Mol Med (2020)

The atypical chemokine receptor 3 interacts with Connexin 43 inhibiting astrocytic gap junctional intercellular communication

od Fumagalli, Amos, Heuninck, Joyce, Pizzoccaro, Anne, Moutin, Enora, Koenen, Joyce, Séveno, Martial, Durroux, Thierry, Junier, Marie-Pierre, Schlecht-Louf, Géraldine, Bachelerie, Francoise, Schütz, Dagmar, Stumm, Ralf, Smit, Martine J., Guérineau, Nathalie C., Chaumont-Dubel, Séverine, Marin, Philippe
Wydane w Nat Commun (2020)

5-HT(6) receptor recruitment of mTOR as a mechanism for perturbed cognition in schizophrenia

od Meffre, Julie, Chaumont-Dubel, Séverine, Mannoury la Cour, Clotilde, Loiseau, Florence, Watson, David J G, Dekeyne, Anne, Séveno, Martial, Rivet, Jean-Michel, Gaven, Florence, Déléris, Paul, Hervé, Denis, Fone, Kevin C F, Bockaert, Joël, Millan, Mark J, Marin, Philippe
Wydane 2012

2-Phenyl-1H-pyrrole-3-carboxamide as a New Scaffold for Developing 5-HT(6) Receptor Inverse Agonists with Cognition-Enhancing Activity

od Drop, Marcin, Canale, Vittorio, Chaumont-Dubel, Séverine, Kurczab, Rafał, Satała, Grzegorz, Bantreil, Xavier, Walczak, Maria, Koczurkiewicz-Adamczyk, Paulina, Latacz, Gniewomir, Gwizdak, Anna, Krawczyk, Martyna, Gołębiowska, Joanna, Grychowska, Katarzyna, Bojarski, Andrzej J., Nikiforuk, Agnieszka, Subra, Gilles, Martinez, Jean, Pawłowski, Maciej, Popik, Piotr, Marin, Philippe, Lamaty, Frédéric, Zajdel, Paweł
Wydane w ACS Chem Neurosci (2021)

International Union of Basic and Clinical Pharmacology. CX. Classification of Receptors for 5-hydroxytryptamine; Pharmacology and Function

od Barnes, Nicholas M., Ahern, Gerard P., Becamel, Carine, Bockaert, Joël, Camilleri, Michael, Chaumont-Dubel, Severine, Claeysen, Sylvie, Cunningham, Kathryn A., Fone, Kevin C., Gershon, Michael, Di Giovanni, Giuseppe, Goodfellow, Nathalie M., Halberstadt, Adam L., Hartley, Rachel M., Hassaine, Ghérici, Herrick-Davis, Katharine, Hovius, Ruud, Lacivita, Enza, Lambe, Evelyn K., Leopoldo, Marcello, Levy, Finn Olav, Lummis, Sarah C. R., Marin, Philippe, Maroteaux, Luc, McCreary, Andrew C., Nelson, David L., Neumaier, John F., Newman-Tancredi, Adrian, Nury, Hugues, Roberts, Alexander, Roth, Bryan L., Roumier, Anne, Sanger, Gareth J., Teitler, Milt, Sharp, Trevor, Villalón, Carlos M., Vogel, Horst, Watts, Stephanie W., Hoyer, Daniel
Wydane w Pharmacol Rev (2021)